Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces Voting Results of Annual Meeting of Shareholders

GlobeNewswire September 20, 2019

DIAGNOS Announces Closing of a Private Placement

GlobeNewswire September 16, 2019

DIAGNOS Announces Private Placement

GlobeNewswire September 13, 2019

DIAGNOS Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia

GlobeNewswire September 10, 2019

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

GlobeNewswire September 3, 2019

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

GlobeNewswire June 20, 2019

DIAGNOS Welcomes Mr. François Côté to its Board of Directors

GlobeNewswire June 18, 2019

DIAGNOS Announces Short Term Financing

GlobeNewswire June 17, 2019

DIAGNOS Announces Corporate Reorganization Update

GlobeNewswire June 10, 2019

DIAGNOS Announces HIPAA Compliance for the US market

GlobeNewswire June 6, 2019

DIAGNOS Announces the Appointment of Mr. Riadh Kobbi as Vice President Business Intelligence

GlobeNewswire June 4, 2019

DIAGNOS Announces the Opening of Two New Screening Clinics in Hafar al-Batin, to Screen 10,000 Patients in the next Six Months With its Partner Kanhoor Medical Co.

GlobeNewswire May 30, 2019

DIAGNOS Adds a Second Screening Site at the CHUM in the Ophthalmology Department

GlobeNewswire May 28, 2019

DIAGNOS Completes Redemption of Convertible Debt

GlobeNewswire May 15, 2019

DIAGNOS Announces Symbol Change on the OTCQB: DGNOD

GlobeNewswire May 8, 2019

DIAGNOS Announces Saudi FDA Filing for its CARA AI Platform

GlobeNewswire May 7, 2019

DIAGNOS Joins Forces with a Cannabis-Based Medicinal Products Distributor

GlobeNewswire May 1, 2019

DIAGNOS Redeems Convertible Debt

GlobeNewswire April 30, 2019

DIAGNOS Successfully Completes ISO 13485:2016 MDSAP Audit

GlobeNewswire April 23, 2019

DIAGNOS Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.

GlobeNewswire April 16, 2019